Annual revenue of Sobi 2009-2023
Annual revenues of Swedish biopharma company Sobi increased from around 6.5 billion Swedish kronor in 2017, up to the highest value of around 22.1 billion Swedish kronor in 2023. The company's full name is Swedish Orphan Biovitrum AB. Sobi is specialized on the treatment of rare diseases. This statistic illustrates the annual revenue of Sobi from 2009 to 2023.